ZyVersa Therapeutics (ZVSA) Misses Q1 EPS by 73c
Tweet
Share
E-mailGet Alerts ZVSA Hot Sheet
Join SI Premium – FREE
ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q1 EPS of ($0.73).
For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
- Citi Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral
- Nike (NKE) call put ratio 2.3 calls to 1 put into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
